Colgate-Palmolive Company
NYSE:CLHousehold & Personal Products
-$0.71 today
- Market cap
- $78.58B
- Beta
- 0.32
- P/E (TTM)
- 34.5
- EPS (TTM)
- $2.60
- Dividend yield
- 2.33%
Volume 6.07M
Average 5.62M
CL EPS (Basic)
Net income attributable to common shareholders divided by the weighted average basic shares outstanding.
Colgate-Palmolive CompanyNYSE: CL
EPS (Basic) · Q3 FY2026 · quarter ended Sep 2026
EPS (Basic) growth accelerates
Q3 FY2026 EPS (Basic) of $0.94 rose 3.3% year over year, ahead of the -28.3% change in trailing-twelve-month EPS (Basic). Sequentially, it rose 8.0% from the prior quarter. Over 3 fiscal years it compounded at +7.4% a year.
Context
- EPS (Basic) increased in 2 of the last 3 fiscal years.
What to watch
Whether EPS (Basic) reaches the consensus estimate from 12 analysts of $3.92 (+48.3%) for the fiscal year ending Dec 2026, a step up from the -25.2% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $0.94+8.0% QoQ
- Last fiscal yearDec 2025
- $2.64-25.2% YoY
- LTMSep 2026
- $2.57-28.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +3.3% | +2228.5% | +2225.2 pp |
| 1 year | -25.2% | +48.3% | +73.5 pp |
| 3-year CAGR | +7.4% | +18.7% | +11.2 pp |
| 5-year CAGR | +12.6% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Basic) history
USD · from the income statement
- Latest · FY2025
- 2.64 USD
- Year-over-year change
- -25.2%
- 4-year CAGR
- +0.8%
| Period | Period end | EPS (Basic) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.64 | -25.2% |
| FY2024 | 2024-12-31 | 3.53 | +27.0% |
| FY2023 | 2023-12-31 | 2.78 | +30.5% |
| FY2022 | 2022-12-31 | 2.13 | -16.8% |
| FY2021 | 2021-12-31 | 2.56 | — |
EPS (Basic) vs competitors
How CL compares with its peers on the latest reported figures
- Peers report in different currencies, so EPS (Basic) is compared through growth and rates rather than absolute size.
- Its year-over-year change of -28.3% is the lowest of 7, against a peer median of -1.1%.
- Over three fiscal years its annual growth of +7.4% compares with a peer median of +2.8%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | $6.75 USD | -4.0% | +3.6% | |
| LTM Jun 2026 | $5.88 USD | -19.2% | +2.0% | |
| LTM Sep 2026 | $5.56 USD | -13.4% | +58.5% | |
| LTM Sep 2026 | $3.26 USD | +1.9% | +21.4% | |
| FY2025 | €2.68 EUR | +16.5% | -3.7% | |
| LTM Sep 2026 | $2.57 USD | -28.3% | +7.4% | |
| LTM Sep 2026 | $0.88 USD | +17.3% | -10.7% | |
| Peer median (excluding CL) | — | -1.1% | +2.8% | |
Competitors are the stored peer set for CL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 17.42B | 17.97B | 19.46B | 20.1B | 20.38B |
| Cost of Revenue | 7.13B | 7.82B | 8.21B | 8B | 8.13B |
| Gross Profit | 10.29B | 10.15B | 11.25B | 12.11B | 12.25B |
| Gross Margin | 59.1% | 56.5% | 57.8% | 60.2% | 60.1% |
| Research & Development | 307M | 320M | 343M | 355M | 366M |
| Selling, General & Admin | 6.1B | 6.25B | 6.78B | 7.81B | 7.89B |
| Operating Expenses | 6.41B | 6.57B | 7.12B | 7.72B | 8.95B |
| Depreciation & Amortization | 556M | 545M | 567M | 605M | 630M |
| EBITDA | 3.76B | 3.37B | 4.25B | 4.85B | 4.87B |
| EBITDA Margin | 21.6% | 18.8% | 21.8% | 24.1% | 23.9% |
| Operating Income | 3.89B | 3.59B | 4.13B | 4.38B | 3.31B |
| Operating Margin | 22.3% | 20.0% | 21.2% | 21.8% | 16.2% |
| Interest Income | 17M | 14M | 55M | 67M | 75M |
| Interest Expense | 117M | 167M | 287M | 292M | 267M |
| Other Income / Expenses | (799M) | (925M) | (739M) | (427M) | (247M) |
| Income Before Tax | 3.09B | 2.66B | 3.39B | 3.96B | 3.06B |
| Pre-Tax Margin | 17.7% | 14.8% | 17.4% | 19.7% | 15.0% |
| Income Tax Expense | 749M | 693M | 937M | 907M | 798M |
| Net Income | 2.17B | 1.79B | 2.3B | 2.89B | 2.13B |
| Net Margin | 12.4% | 9.9% | 11.8% | 14.4% | 10.5% |
| EPS (Basic) | 2.56 | 2.13 | 2.78 | 3.53 | 2.64 |
| EPS (Diluted) | 2.55 | 2.13 | 2.77 | 3.51 | 2.63 |
| Weighted Avg Shares | 845M | 836.4M | 827.4M | 817.7M | 808.7M |
| Weighted Avg Shares (Diluted) | 848.3M | 838.8M | 829.2M | 822.5M | 811.1M |
Colgate-Palmolive Company
NYSE:CL
Intrinsic Alpha fair value
Locked
Current Price
$98.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.